Phase I study of VR647 in patients with Asthma
Phase of Trial: Phase I
Latest Information Update: 06 Sep 2017
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Adverse reactions
- 06 Sep 2017 According to a Vectura media release, dosing in this trial was completed in June 2017.
- 06 Sep 2017 Status changed from planning to completed, according to a Vectura media release
- 24 Jan 2017 According to a Vectura media release, this study is expected to initiate in H1 2017.